Sudipto Mukherjee

3.8k total citations
139 papers, 1.2k citations indexed

About

Sudipto Mukherjee is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Sudipto Mukherjee has authored 139 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Hematology, 55 papers in Genetics and 33 papers in Oncology. Recurrent topics in Sudipto Mukherjee's work include Acute Myeloid Leukemia Research (87 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (39 papers) and Acute Lymphoblastic Leukemia research (26 papers). Sudipto Mukherjee is often cited by papers focused on Acute Myeloid Leukemia Research (87 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (39 papers) and Acute Lymphoblastic Leukemia research (26 papers). Sudipto Mukherjee collaborates with scholars based in United States, Italy and India. Sudipto Mukherjee's co-authors include Mikkael A. Sekeres, Jaroslaw P. Maciejewski, Hetty E. Carraway, Aaron T. Gerds, Matt Kalaycio, Anjali S. Advani, Tomas Radivoyevitch, Aziz Nazha, Clyde Guidry and Remco J. Molenaar and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Sudipto Mukherjee

124 papers receiving 1.2k citations

Peers

Sudipto Mukherjee

HEMAT

ONCOL

GENET

PHEOH

Patrick Hilden United States

Valéria Buccheri Brazil

Jae‐Sook Ahn South Korea

Taiga Nishihori United States

Deok‐Hwan Yang South Korea

Carol Reynolds United States

Elena Oldani Italy

Irena Sniecinski United States

Sunil Babu United States

Rika Sakai Japan

Patrick Hilden United States

Sudipto Mukherjee

334 ×0.6

HEMAT

341 ×1.1

ONCOL

223 ×0.8

GENET

132 ×0.5

126 ×0.7

PHEOH

Citations per year, relative to Sudipto Mukherjee Sudipto Mukherjee (= 1×) peers Patrick Hilden

Countries citing papers authored by Sudipto Mukherjee

Since Specialization

Citations

This map shows the geographic impact of Sudipto Mukherjee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sudipto Mukherjee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sudipto Mukherjee more than expected).

Fields of papers citing papers by Sudipto Mukherjee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sudipto Mukherjee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sudipto Mukherjee. The network helps show where Sudipto Mukherjee may publish in the future.

Co-authorship network of co-authors of Sudipto Mukherjee

This figure shows the co-authorship network connecting the top 25 collaborators of Sudipto Mukherjee. A scholar is included among the top collaborators of Sudipto Mukherjee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sudipto Mukherjee. Sudipto Mukherjee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Patel, Meera, Emily C. Zabor, Hadil Zureigat, et al.. (2025). Impact of TP53 mutation on survival outcomes in acute lymphoblastic leukemia at a tertiary center. Leukemia & lymphoma. 66(8). 1509–1514.

Franklin, Matthew, et al.. (2024). Internal Psychometric Validation of an International Burden of Illness Survey for Idiopathic Multicentric Castleman Disease. Oncology and Therapy. 12(3). 491–508. 1 indexed citations

Garcia‐Manero, Guillermo, Rayna K. Matsuno, Ali McBride, et al.. (2024). Clinical Outcomes and Healthcare Resource Utilization for Patients With Lower-Risk Myelodysplastic Syndromes Treated With Erythropoiesis-Stimulating Agents. Clinical Lymphoma Myeloma & Leukemia. 24(9). e283–e292.

Mukherjee, Sudipto, et al.. (2023). Symptom burden in patients with idiopathic multicentric Castleman disease and its impact on daily life: an international patient and caregiver survey. EClinicalMedicine. 64. 102192–102192. 4 indexed citations

Mukherjee, Sudipto, et al.. (2023). P733: TREATMENT PATTERNS AND OUTCOMES AMONG PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES RECEIVING LUSPATERCEPT IN ROUTINE CLINICAL PRACTICE IN THE UNITED STATES. HemaSphere. 7(S3). e648138a–e648138a.

Mukherjee, Sudipto, Xiting Cao, Rodrigo Maegawa, et al.. (2020). Effectiveness of Second-Line (2L) Tyrosine Kinase Inhibitor (TKI) Therapy after Resistance or Intolerance to a Prior TKI in Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase (Ph+ CML-CP). Blood. 136(Supplement 1). 17–18.

Mukherjee, Sudipto, Hong Li, Brian P. Hobbs, et al.. (2019). A Single Arm, Phase II Study of Eltrombopag to Enhance Platelet Count Recovery in Older Patients with Acute Myeloid Leukemia (AML) Undergoing Remission Induction Therapy. Blood. 134(Supplement_1). 2595–2595. 1 indexed citations

Molenaar, Remco J., Tomas Radivoyevitch, Yasunobu Nagata, et al.. (2018). IDH1/2 Mutations Sensitize Acute Myeloid Leukemia to PARP Inhibition and This Is Reversed by IDH1/2-Mutant Inhibitors. Clinical Cancer Research. 24(7). 1705–1715. 79 indexed citations

Madanat, Yazan F., Mikkael A. Sekeres, Sudipto Mukherjee, et al.. (2018). Genomic Biomarkers Predict Response/Resistance to Lenalidomide in Non-Del(5q) Myelodysplastic Syndromes. Blood. 132(Supplement 1). 1797–1797. 6 indexed citations

10.

Hirsch, Cassandra M., Michael J. Clemente, Vera Ademà, et al.. (2017). High Frequency of Subclonal Myeloid Mutations Can be Found in Large Granular Lymphocyte Leukemia. Blood. 130. 1171–1171. 1 indexed citations

11.

Madanat, Yazan F., Tomas Radivoyevitch, Aziz Nazha, et al.. (2017). Mutational Signatures Associated with Intensity and Duration of Smoking in Myelodysplastic Syndromes (MDS). Blood. 130. 424–424. 1 indexed citations

12.

Madanat, Yazan F., Sudipto Mukherjee, Cassandra M. Hirsch, et al.. (2017). Model Heterogeneity in Predicting Outcomes of Patients with Myelodysplastic Syndromes (MDS). Blood. 130. 2972–2972. 2 indexed citations

13.

Molenaar, Remco J., Tomas Radivoyevitch, Mikkael A. Sekeres, Sudipto Mukherjee, & Jaroslaw P. Maciejewski. (2017). High Rates of Atherosclerotic Disease-Related Mortality in Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia Patients Associated with TET2-Mutations. Blood. 130. 421–421. 1 indexed citations

14.

Abuhadra, Nour, Sudipto Mukherjee, Cassandra M. Hirsch, et al.. (2017). BCOR Mutations in Myelodysplastic Syndromes (MDS): Mutation Characteristics Impact Clinical Outcomes. Blood. 130. 5304–5304. 3 indexed citations

15.

Ahmed, Hina, Sagar S. Patel, Bhumika Patel, et al.. (2017). Predictors for Recurrent 30-Day Unplanned Readmissions in Patients with Hematologic Malignancies. Blood. 130. 532–532. 1 indexed citations

16.

Mukherjee, Sudipto, Aziz Nazha, Anjali S. Advani, et al.. (2017). No Excess Risk of Second Malignancies in Chronic Myeloid Leukemia (CML) Patients Treated with Tyrosine Kinase Inhibitors (TKIs). Blood. 130. 2872–2872. 2 indexed citations

17.

Sekeres, Mikkael A., Babal K. Jha, Bartlomiej Przychodzen, et al.. (2016). TP53 Mutations and Outcome in Patients with Myelodysplastic Syndromes (MDS). Blood. 128(22). 4336–4336. 9 indexed citations

18.

Ebrahem, Quteba, Reda Z. Mahfouz, Lisa Durkin, et al.. (2015). Mechanisms of Resistance to 5-Azacytidine/Decitabine in MDS-AML and Pre-Clinical In Vivo Proof of Principle of Rational Solutions to Extend Response. Blood. 126(23). 678–678. 6 indexed citations

19.

Sidana, Surbhi, Sudipto Mukherjee, Paul Elson, et al.. (2013). The Degree and Effect Of Weight Loss In Acute Myeloid Leukemia Patients Receiving Induction and Post-Remission Chemotherapy. Blood. 122(21). 3889–3889. 3 indexed citations

20.

Cerfolio, Robert J., et al.. (2003). Positron emission tomography scanning with 2-fluoro-2-deoxy-d-glucose as a predictor of response of neoadjuvant treatment for non-small cell carcinoma. Journal of Thoracic and Cardiovascular Surgery. 125(4). 938–944. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact